Low dose of hydroxychloroquine is associated with reduced COVID-19 mortality: a multicenter study in China

Wu He(Tongji Hospital), Dao Wen Wang(Tongji Hospital), Ke Xu(Chinese Academy of Sciences), Gen Li(Tongji Hospital), Bo Yu(Tongji Hospital), Junfang Wu(Laboratory of Molecular Genetics), Da Zhou(Health and Family Planning Commission of Hubei Province), Kaineng Zhong(Health and Family Planning Commission of Hubei Province), Yongcui Yan(Tongji Hospital)
Frontiers of Medicine
March 4, 2025
10.1007/s11684-025-1123-9
Cited by 1

Related Papers

SARS-CoV-2: a potential novel etiology of fulminant myocarditis
|Herz|2020|421
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
Gut Microbiota Composition Modifies Fecal Metabolic Profiles in Mice
|Journal of Proteome Research|2013|225
Synchronized age-related gene expression changes across multiple tissues in human and the link to complex diseases
|Scientific Reports|2015|224
Polyunsaturated Fatty Acids from Astrocytes Activate PPARγ Signaling in Cancer Cells to Promote Brain Metastasis
|Cancer Discovery|2019|184